In Vivo Thrombogenicity of Embolic Protection Systems for Angioplasty and Stenting

Despite the increasing use of embolic protection systems (EPS) for carotid stenting, their intrinsic in vivo thrombogenicity remains unknown. We studied three different types of EPS (n = 24) deployed in the carotid arteries of pigs in which pools of platelets and fibrinogen were labelled with 111In and 125I. The amount of clot deposition seen on photography was also scored using a qualitative scale. EPS made of fabric nets under normal flow conditions were 5–6 and 15–16 times more thrombogenic (for both platelet (P=.04) and fibrin (P=.007)) than Nitinol mesh nets. Clot deposition on Nitinol mesh nets was more abundant under flow arrest than under normal flow conditions (P=.018). EPS differ in intrinsic thrombogenicity, a characteristic of the material that could be investigated in pre-clinical studies designed to optimize devices.

[1]  A. Lunghi,et al.  Angioplasty and stenting of the cervical carotid bifurcation under filter protection: a prospective study in a series of 53 patients. , 2005, Journal of neuroradiology. Journal de neuroradiologie.

[2]  Y. Isaka,et al.  Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods , 1999, European Journal of Nuclear Medicine.

[3]  S. Hanson,et al.  Blood flow and antithrombotic drug effects. , 1998, American heart journal.

[4]  L. Bush,et al.  In vivo models of arterial thrombosis and thrombolysis , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  M. Dewanjee Methods of Assessment of Thrombosis in Vivo , 1987, Annals of the New York Academy of Sciences.